JPRN-jRCT1032220207招募中未知
Early diagnosis and treatment of thrombocytopenia and hypofibrinogenemia in cardiac surgery using novel viscoelastic testing devise,Quantra-Qplus system
Takano Hiroshi0 个研究点目标入组 50 人开始时间: 2022年7月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 18age old 至 ot applicable(—)
- 性别
- All
入选标准
- •1)Patients with written informed consent
- •2)Caridiovascular surgery patients using cardiopulmonary bypass
- •3)Patients over 18 years of age at the time of concent
排除标准
- •1)Patients undergoing emergency surgery
- •2)Patients who may be pregnant
- •3)Heart transplant surgery.
- •4)Cardiac surgey reoperation .
研究者
相似试验
进行中(未招募)
不适用
Eltrombopag for the treatment of thrombocytopenia due to low- and intermediate risk myelodysplastic syndromes.Adult subjects (18 yearsof age or older) with lowor intermediate-1 IPSSrisk MDS andthrombocytopeniaMedDRA version: 18.0Level: HLTClassification code 10028536Term: Myelodysplastic syndromesSystem Organ Class: 100000004851EUCTR2010-022890-33-FRASSOCIAZIONE QOL-ONE171
进行中(未招募)
1 期
Eltrombopag for the treatment of thrombocytopenia due to low- and intermediate risk myelodysplastic syndromes.EUCTR2010-022890-33-SIASSOCIAZIONE QOL-ONE174
招募中
2 期
Eltrombopag for the treatment of thrombocytopenia due to low - and intermediate risk myelodysplastic syndromes.2024-520133-72-00Associazione Qol-One160
未知
3 期
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective ProcedureThrombocytopenia Associated With Chronic Liver DiseaseJPRN-jRCT2080222694Eisai Co., Ltd.300
进行中(未招募)
1 期
Treatment of low platelets in patients suffering from Immune Thrombocytopenia with eltrombopag (oral drug) versus IVIG (intravenous immune globuline) who are in need of surgery.Immune thrombocytopenia patients with low platelets and in need of surgery.MedDRA version: 19.0Level: LLTClassification code 10023095Term: ITPSystem Organ Class: 100000004851EUCTR2016-004295-22-NLHagaziekenhuis74
